Gajendra P S Raghava Selected Research

Subunit Vaccines

1/2021

In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gajendra P S Raghava Research Topics

Disease

31	Neoplasms (Cancer) 02/2022 - 07/2009
5	COVID-19 02/2022 - 12/2020
4	Carcinogenesis 02/2022 - 10/2019
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2012
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 04/2008
2	Infections 01/2022 - 12/2013
2	Papillary Thyroid Cancer 01/2021 - 01/2020
2	Hypersensitivity (Allergy) 01/2021 - 05/2005
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2014
2	Tuberculosis (Tuberculoses) 01/2018 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014 - 02/2014
1	Hyperplasia 02/2022
1	Respiratory Hypersensitivity 02/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Central Nervous System Diseases (CNS Diseases) 11/2021
1	Cytokine Release Syndrome 10/2021
1	Acute-Phase Reaction 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Disease Progression 04/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Kidney Neoplasms (Kidney Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 03/2014
1	Parasitic Diseases (Parasitic Disease) 01/2014
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Osteoporosis 07/2009

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2013
12	Peptides (Polypeptides)IBA 02/2022 - 05/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
10	Pharmaceutical PreparationsIBA 12/2020 - 01/2013
7	VaccinesIBA 01/2021 - 05/2005
3	EpitopesIBA 01/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
3	Pattern Recognition ReceptorsIBA 01/2020 - 04/2008
3	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2019
2	CytokinesIBA 10/2021 - 01/2021
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019 - 04/2008
2	AntigensIBA 01/2016 - 01/2010
2	Amino Acids FDA Link 01/2013 - 01/2012
1	Interleukin-13IBA 02/2022
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	HLA-G Antigens (HLA G)IBA 01/2022
1	Perindopril FDA LinkGeneric 10/2021
1	Tamoxifen FDA LinkGeneric 10/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Subunit VaccinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	AllergensIBA 01/2021
1	talimogene laherparepvecIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	transcription factor NF-AT c3IBA 10/2019
1	EnzymesIBA 01/2019
1	LigandsIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	Trastuzumab (Herceptin)FDA Link 03/2014
1	Monoclonal AntibodiesIBA 03/2014
1	QuinazolinesIBA 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 12/2013
1	Complement System Proteins (Complement)IBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2012
1	NGR peptideIBA 01/2012
1	arginyl-glycyl-aspartic acidIBA 01/2012
1	Peptide Receptors (Peptide Receptor)IBA 01/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Hormones (Hormone)IBA 07/2009

Therapy/Procedure

10	Therapeutics 02/2022 - 01/2013
7	Immunotherapy 01/2022 - 01/2010
1	Drug Therapy (Chemotherapy) 01/2022
1	Organ Transplantation 01/2019
1	Precision Medicine 03/2016